By extending earlier preclinical work on GLP-1 receptor agonists and alcohol intake to a task that directly assesses the subjective effects of alcohol, these findings provide important context for interpreting clinical observations of reduced drinking behavior among individuals receiving GLP-1 receptor-based therapies
S., Bogler, T., & Maxwell, C
Body Mass Index equal to or greater than 35 with at least two of the following comorbidities
The Numbers That Matter: In the landmark SURMOUNT-5 trial published in the New England Journal of Medicine in May 2025, participants taking tirzepatide lost an average of 20.2% of their body weight over 72 weeks, compared to 13.7% with semaglutide
The researchers found a significant difference in body weight in the treatment group receiving a 14 mg dosage of Rybelsus
Similarly, certain psychosocial or interpersonal factors (eg, intimacy, shared values, romance, certain experiences and/or behaviors) can heighten a womans sexual desire and response, whereas others (eg, relationship conflict, negative stress, negative beliefs about sex, certain experiences and/or behaviors) do the reverse